EP0409845A4 - Method for protection from chemotherapeutic side effects - Google Patents

Method for protection from chemotherapeutic side effects

Info

Publication number
EP0409845A4
EP0409845A4 EP19890902904 EP89902904A EP0409845A4 EP 0409845 A4 EP0409845 A4 EP 0409845A4 EP 19890902904 EP19890902904 EP 19890902904 EP 89902904 A EP89902904 A EP 89902904A EP 0409845 A4 EP0409845 A4 EP 0409845A4
Authority
EP
European Patent Office
Prior art keywords
protection
side effects
chemotherapeutic side
chemotherapeutic
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890902904
Other versions
EP0409845A1 (en
Inventor
Philip S. Schein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of EP0409845A1 publication Critical patent/EP0409845A1/en
Publication of EP0409845A4 publication Critical patent/EP0409845A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP19890902904 1988-02-23 1989-02-21 Method for protection from chemotherapeutic side effects Withdrawn EP0409845A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15910488A 1988-02-23 1988-02-23
US159104 1988-02-23

Publications (2)

Publication Number Publication Date
EP0409845A1 EP0409845A1 (en) 1991-01-30
EP0409845A4 true EP0409845A4 (en) 1991-07-03

Family

ID=22571099

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890902904 Withdrawn EP0409845A4 (en) 1988-02-23 1989-02-21 Method for protection from chemotherapeutic side effects

Country Status (5)

Country Link
EP (1) EP0409845A4 (en)
JP (1) JPH03503888A (en)
AU (1) AU636107B2 (en)
CA (1) CA1336506C (en)
WO (1) WO1989007942A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (en) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh COMBINATION PREPARATIONS OF PROTEINKINASE-C INHIBITORS WITH LIPIDS, LIPID ANALOGS, CYTOSTATICA OR INHIBITORS OF PHOSPHOLIPASES
US5567686A (en) * 1992-03-13 1996-10-22 Arch Development Corporation Method for protection against genotoxic mutagenesis
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US6239119B1 (en) 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
US6489312B1 (en) 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
CN102260288B (en) * 2010-06-08 2014-02-26 成都大有得药业有限公司 Synthesis method of 3-amino-propyl aminoethyl thiophosphate trihydrate
RU2450791C1 (en) * 2010-10-18 2012-05-20 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Method for determining cardiotoxic complications in patients with chronic lymphatic leukemia
CN104230984B (en) * 2013-06-08 2017-02-08 国药集团国瑞药业有限公司 Preparation method for trihydrate 3-amino propyl aminoethyl thiophosphoric acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
American Association for Cancer Research Proceedings, Vol. 22, March 1981, page 271, Abstract No. 1075, Washington, DC, US; T.L. PHILLIPS et al.: "Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs, intestinal crypt cells, EMT6 tumor", whole article. *
Drugs of the Future, Vol. 14, No. 11, November 1989, pages 1105-1107; whole article. *
J. Pharmacobio.-Dynamics, Vol. 3, No. 7, July 1980, page s-21; M. ONODA et al.: "Effect of various kinds of drugs in vitro on the proliferation of leukopoietic stem cells (CFU-C)", whole article. *
Proceedings of the 9th Annual Conference of the IEEE Engineering in Medicine and Biology Society, Boston, 13th-16th November 1987, pages 1443-1445, New York, US; M.-A. RIX-MONTEL: "Radioprotective effects of thiophosphates", whole article. *
See also references of WO8907942A1 *

Also Published As

Publication number Publication date
WO1989007942A1 (en) 1989-09-08
EP0409845A1 (en) 1991-01-30
AU636107B2 (en) 1993-04-22
JPH03503888A (en) 1991-08-29
AU3194089A (en) 1989-09-22
CA1336506C (en) 1995-08-01

Similar Documents

Publication Publication Date Title
EP0351115A3 (en) Packaging method
GB8814705D0 (en) Method
ZA89855B (en) Method for preventing secondary effects
GB2214602B (en) Line protecting apparatus
ZA858832B (en) Theft prevention apparatus
HUT54819A (en) Arrangement for slot-machines
EP0409845A4 (en) Method for protection from chemotherapeutic side effects
GB8822145D0 (en) Method
GB8827847D0 (en) Method
GB8628165D0 (en) Mine for protection from moving objects
EG18973A (en) Method for preventing scale formation
GB8829942D0 (en) Method
GB8801810D0 (en) Conveyor system
GB8810057D0 (en) Conveyor system
GB8801564D0 (en) Protection
EP0327273A3 (en) Dyeimage forming method
GB8908036D0 (en) Erosion protection
GB2227757B (en) Protection method
GB8810354D0 (en) Method
GB9200682D0 (en) Noncorruptible read-writer method
GB8808202D0 (en) Protection system
GB9021378D0 (en) Erosion protection
BG47208A1 (en) Method for tymphanostomy
GB8829580D0 (en) Packaging equipment
GB8812092D0 (en) Protection apparatus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900823

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910516

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920305

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930513